Lucrin Depot Paediatric leuprorelin acetate 30mg for injection, prefilled dual chamber syringe (single dose)

Official notice

3 Oct 2017

Last checked

3 Oct 2017

Low riskACCC

An official ACCC notice concerns Lucrin Depot Paediatric leuprorelin acetate 30mg for injection, prefilled dual chamber syringe (single dose). If the contents of the syringe are injected, it could result in the incomplete delivery of medication and the patient receiving a sub-therapeutic dose. Injection of affected medication could also result in increased irritation or reaction at the injection site. Published 2017-10-03.

What to do now

If you, or somebody you care for, is taking Lucrin Depot Paediatric 30mg PDS, please be alert to this issue. Check any prefilled syringes that you have and if they are from lot number 1078155, return them to your pharmacy for refund or replacement. All pre-filled syringes should be routinely inspected before use and if you notice anything unusual, consult a health professional. Further information is available from AbbVie Medical Information on 1800 043 460.

Recall number

4c63c8f5-1c6b-4f9e-bb30-d0cabd8610bd

Official notice

2017-10-03

The hazard

If the contents of the syringe are injected, it could result in the incomplete delivery of medication and the patient receiving a sub-therapeutic dose. Injection of affected medication could also result in increased irritation or reaction at the injection site.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

only, 1078155, is, return

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

One lot only - 1078155. The lot number is displayed on the left side of the front panel of the packs (see image). Expiry 31/12/2019 Supplied from 2 August 2017 Lucrin Depot Paediatric 30mg PDS is used to treat central precocious puberty, a condition causing children to enter puberty prematurely. AUST R: 218936

Risk / hazard

If the contents of the syringe are injected, it could result in the incomplete delivery of medication and the patient receiving a sub-therapeutic dose. Injection of affected medication could also result in increased irritation or reaction at the injection site.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

AU · Australia

Affected area 1

AU · Australia

Source & status

Source

Tier

beta

Category

HOME

Classification

Pharmacy and medical products

App estimate

low

Recall details

Recall number

4c63c8f5-1c6b-4f9e-bb30-d0cabd8610bd

Classification

Pharmacy and medical products

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 3 Oct 2017. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.